Indications
Symptomatic relief in the treatment of osteoarthritis or rheumatoid arthritis.Treatment of primary dysmenorrhoea.
Composition
- Active substance
- valdecoxib
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Valdyn (previously Kudeq)
- Active substance
- valdecoxib
- ATC code
- M01AH03
- Therapeutic area
- Arthritis, Rheumatoid, Osteoarthritis, Dysmenorrhea
- Marketing authorisation holder
- Pfizer Limited
- Status
- Withdrawn
- EU authorisation
- 27 Mar 2003